SciClone Pharmaceuticals Inc. (SCLN)
Symbol Info
Listed Symbol SCLN
Name SciClone Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $160,096,000
Latest Fiscal EPS $0.58
Price Info
21 Day Moving Average $11.1298
21 Day EMA $11.122030
50 Day Moving Average $11.0850
50 Day EMA $11.046890
200 Day EMA $10.604580
200 Day Moving Average 10.383630
52 Week High $11.43
52 Week Low $8.55
52 Week Change $11.277400
Alpha 0.000375
Beta 1.7357
Standard Deviation 0.117550
R2 0.161393
Periods 60
Share Information
10 Day Average Volume 544,066
20 Day Average Volume 493,218
30 Day Average Volume 469,953
50 Day Average Volume 446,402
Outstanding Shares 52,191,854
Float Shares 49,551,383
Percent Float 94.94%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 214
Institute Holdings Date 2017-09-30
Institute Bought Previous 3 Months 4,343,650
Institute Holdings Percent 89.100000
Institute Sold Previous 3 Months 5,313,999
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,640,471
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0499992
21 Day Percent Change 0.45%
30 Day Price Change $0.0499992
30 Day Percent Change 0.45%
Month To Date Price Change $-0.05
Month To Date Percent -0.45%
90 Day Price Change $0.224999
90 Day Percent Change 2.06%
Quarter To Date $-0.05
Quarter To Date Percent -0.45%
180 Day Price Change $1.549999
180 Day Percent Change 16.15%
200 Day Price Change $1.349999
200 Day Percent Change 13.78%
Year To Date $0.349999
Year To Date Percent 3.24%
Profile
Description SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.
Details
Issue Type CS
Market Cap $581,939,172
Sec Type EQS
Auditor PricewaterhouseCoopers Zhong Tian LLP
Total Shares Outstanding -
CEO Friedhelm Blobel
Employees 570
Last Audit UQ
Classification
CIK 0000880771
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 950 Tower Lane
Suite 900
Foster City, CA 94404
Website http://www.sciclone.com
Facisimile +1 650 358-3469
Telephone +1 650 358-3456
Email investorrelations@sciclone.com
Key Ratios
Profitability
EBIT Margin 25.80
EBITDA Margin 26.4
Pre-Tax Profit Margin 14.9
Profit Margin Cont 24.73
Gross Margin 86.50
Profit Margin TOT 24.73
Income Statements
Revenue $131,474,000
Revenue Per Share $2.5191
Revenue 3 Years $3.63
Revenue 5 Years $-0.25
Valuation Measures
PE Ratio 13.60
Enterprise Value $424,611,172
Price To Sales 4.426268
Price To Free Cash 25.600000
PE High Last 5 Years 51.5
Price To Book 2.3
Price To Cash Flow 16.5
PE Low Last 5 Years 8.4
Price To Tangible Book 2.7
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 8.4
Leverage Ratio 1.1
Quick Ratio 7.4
Long Term Debt To Capital -
Assets
Receivables Turnover 3.2
Invoice Turnover 1.30
Assets Turnover 0.60
Management Effectiveness
Return Assets 17.39
Return On Equity 19.32
Return On Capital 19.09
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SCLN
Sciclone
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.